Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Gilead Sciences, Inc. (GILD) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gilead Sciences, Inc. (GILD) - free report >>
Image: Bigstock
New Strong Sell Stocks for June 21st
• Advanced Drainage Systems, Inc. (WMS - Free Report) is a manufacturer of thermoplastic corrugated pipe, providing a comprehensive suite of water management products and drainage solutions for use in the construction and infrastructure marketplace. The Zacks Consensus Estimate for its current year earnings has been revised 11.2% downward over the last 30 days.
• Encore Capital Group, Inc. (ECPG - Free Report) is a leading provider of debt management and recovery solutions for consumers and property owners across a broad range of assets. The Zacks Consensus Estimate for its current year earnings has declined 1.3% over the last 30 days.
• Federated Investors, Inc. is a provider of investment management and related financial services. It has seen the Zacks Consensus Estimate for its current year earnings being revised 1.3% downward over the last 30 days.
• Francesca's Holdings Corporation is a specialty retailer of women's apparel products. The Zacks Consensus Estimate revision for its current year earnings was a negative 7.7% over the last 30 days.
• Gilead Sciences Inc. (GILD - Free Report) is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. The Zacks Consensus Estimate for its current year earnings has moved 1.5% lower over the last 30 days.
View the entire Zacks Rank #5 List